BACKGROUND CONTEXT: Pain patients often report cognitive symptoms, and many will include them in their claims of disability. There is empirical evidence that patients with pain do experience problems on attention-demanding cognitive tasks, but the results are mixed and the potential impact of exaggeration in the context of pain-related litigation has not been addressed. PURPOSE: 1) Examine the impact of pain and malingering on attention; 2) determine if the Working Memory Index (WMI) of the Wechsler Adult Intelligence Scale-3 (WAIS-III) can reliably detect malingering. STUDY DESIGN/ SETTING: Study 1: simulator design; Study 2: clinical known-groups design. PATIENT SAMPLE: Study 1 used healthy college students; Study 2 used chronic pain patients and neurological patients. OUTCOME MEASURES: The WMI and its constituent subtests. METHODS: Study 1: College students were administered the WMI under three conditions: standard administration, with cold-pressor induced pain, or with instructions to simulate impairment due to pain. Study 2: Known-groups design in which the WMI was examined in non-malingering and definite malingering chronic pain patients, non-malingering moderate-severe traumatic brain injury, and memory disorder patients seen for routine psychological evaluation. Malingering was operationalized using published criteria. RESULTS: There were no group differences in WMI or its subtests among non-malingering groups, but some individual clinical patients with pain did score at a level suggestive of attentional impairment. The lowest scores were found in the simulated malingering college students and definite malingering clinical pain groups, in which about half scored worse than 95% of the non-malingering clinical patients. CONCLUSIONS: This study demonstrated that even when controlling for exaggeration some pain patients do exhibit problems with attentional function. However, significant impairment in WMI performance (eg, index score<or=70), particularly in the absence of brain dysfunction, cannot reasonably be attributed to the effects of either acute or chronic pain, even at moderate to severe levels, and likely reflects intentional exaggeration.
BACKGROUND CONTEXT: Painpatients often report cognitive symptoms, and many will include them in their claims of disability. There is empirical evidence that patients with pain do experience problems on attention-demanding cognitive tasks, but the results are mixed and the potential impact of exaggeration in the context of pain-related litigation has not been addressed. PURPOSE: 1) Examine the impact of pain and malingering on attention; 2) determine if the Working Memory Index (WMI) of the Wechsler Adult Intelligence Scale-3 (WAIS-III) can reliably detect malingering. STUDY DESIGN/ SETTING: Study 1: simulator design; Study 2: clinical known-groups design. PATIENT SAMPLE: Study 1 used healthy college students; Study 2 used chronic painpatients and neurologicalpatients. OUTCOME MEASURES: The WMI and its constituent subtests. METHODS: Study 1: College students were administered the WMI under three conditions: standard administration, with cold-pressor induced pain, or with instructions to simulate impairment due to pain. Study 2: Known-groups design in which the WMI was examined in non-malingering and definite malingering chronic painpatients, non-malingering moderate-severe traumatic brain injury, and memory disorderpatients seen for routine psychological evaluation. Malingering was operationalized using published criteria. RESULTS: There were no group differences in WMI or its subtests among non-malingering groups, but some individual clinical patients with pain did score at a level suggestive of attentional impairment. The lowest scores were found in the simulated malingering college students and definite malingering clinical pain groups, in which about half scored worse than 95% of the non-malingering clinical patients. CONCLUSIONS: This study demonstrated that even when controlling for exaggeration some painpatients do exhibit problems with attentional function. However, significant impairment in WMI performance (eg, index score<or=70), particularly in the absence of brain dysfunction, cannot reasonably be attributed to the effects of either acute or chronic pain, even at moderate to severe levels, and likely reflects intentional exaggeration.
Authors: Jonathan Nissenbaum; Marshall Devor; Ze'ev Seltzer; Mathias Gebauer; Martin Michaelis; Michael Tal; Ruslan Dorfman; Merav Abitbul-Yarkoni; Yan Lu; Tina Elahipanah; Sonia delCanho; Anne Minert; Kaj Fried; Anna-Karin Persson; Hagai Shpigler; Erez Shabo; Benjamin Yakir; Anne Pisanté; Ariel Darvasi Journal: Genome Res Date: 2010-08-05 Impact factor: 9.043
Authors: André Strahl; Murteza Ali Kazim; Nils Kattwinkel; Wiebke Hauskeller; Steffen Moritz; Sönke Arlt; Andreas Niemeier Journal: Bone Joint J Date: 2022-03 Impact factor: 5.385
Authors: Amy Lee Bredlau; Brian T Harel; Michael P McDermott; Robert H Dworkin; David N Korones; James G Dolan; Heather R Adams Journal: J Palliat Care Med Date: 2015-03-27